Keep reading to find out more about microdosing GLP-1s, how they can help with menopause-related weight gain, and what to know about trying it yourself
FDA Press Release on First Treatment for Menkes Disease Rare Disease: FDA Expands Treatment Approval for Gaucher Disease The FDA expanded the approval of Sanofis Cerezyme (imiglucerase) intravenous infusion enzyme replacement therapy to treat non-neurological symptoms in patients with Type 3 Gaucher disease, which is the rarest and most serious type
Sometimes I never felt a thing and other times it hurt, especially if a nurse was stressed or rushed
Additionally, genetic studies have uncovered a fascinating link: a naturally occurring variant of the MOTS-c peptide (in which a single amino acid, glutamate, is replaced by lysine at a certain position) has been associated with exceptional longevity in some populations
GLP-1s work by mimicking hormones that your gut normally releases after eating
Combined hormone reversal therapy (elagolix 300 mg/estradiol 1 mg/norethindrone acetate 0.5 mg) mitigated the low estrogen effect of elagolix, demonstrating superior efficacy in preventing bone density decline [161]
